Cancer of the oro- and hypopharynx - When to expect recurrences?

Acta Oto-Laryngologica

Volumn 128, Issue 8, 2008, Pages 925-929

  Sesterhenn, Andreas M ^a   Müller, Hans Helge ^a   Wiegand, Susanne ^a   Teymoortash, Afshin ^a   Folz, Benedikt J ^a   Werner, Jochen A ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cancer; Hypopharynx; Oropharynx; Recurrence; SCC

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; DISEASE COURSE; FEMALE; HUMAN; HYPOPHARYNX CANCER; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 46849108297     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480701762474     Document Type: Article

References (16)

1. Hoffman HT, Karnell LH, Shah JP, Ariyan S, Brown GS, Fee WE, et al. Hypopharyngeal cancer patient care evaluation. Laryngoscope 1997;107:1005-17.
2. Pingree TF, Davis RK, Reichman O, Derrick L. Treatment of hypopharyngeal carcinoma: a 10-year review of 1,362 cases. Laryngoscope 1987;97:901-4.
3. Schlesinger-Raab A, Lang S, Steuer-Vogt MK, Hölzel D. Zur Epidemiologie der Kopf-Hals-Malignome. In: Wollenberg B, Zimmermann, editors. Manual Kopf-Hals-Malignome. München: Zuckschwerdt; 2003. p. 3-14.
4. Donath K. Biologische Grundlagen und Pathologie des Tumorrezidivs. In: Böttcher HD, Wendt TG, Henke M, editors. Klinik des Rezidivtumors im Kopf-Hals-Bereich. München: Zuckschwerdt; 2001. p. 1-6.
5. Werner JA, Dünne AA, Folz BJ, Lippert BM. Transoral laser microsurgery in carcinomas of the oral cavity, pharynx, and larynx. Cancer Control 2002;9:379-86.
6. Bier H, Schultze M, Ganzer U. Anmerkungen zur Nachsorge von Tumorpatienten. HNO 1993;41:47-54.
7. van den Brekel MW, Castelijns JA, Stel HV, Luth WJ, Valk J, van der Waal I, et al. Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology 1991;180:457-61.
8. Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J. Second neoplasm in patients with head and neck cancer. Head Neck 1999;21:204-10.
9. Wong LY, Wei WI, Lam LK, Yuen AP. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck 2003;25:953-9.
10. Werner JA, Davis RK. Post-therapeutic follow-up principles. In: Werner JA, Davis RK, editors. Metastases in head and neck cancer. Berlin: Springer; 2004. p. 227.
11. Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992;28:426-30.
12. Paniello RC, Virgo KS, Johnson MH, Clemente MF, Johnson FE. Practice patterns and clinical guidelines for posttreatment follow-up of head and neck cancers: a comparison of 2 professional societies. Arch Otolaryngol Head Neck Surg 1999;125:309-13.
13. Wolfensberger M. Aufwand und Nutzen regelmäßiger Nachkontrollen bei Patienten mit Pflasterzellkarzinomen des Larynx, der Mundhöhle und des Pharynx. HNO 1988;36:28-32.
14. Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 2000;110:1-18.
15. Stell PM. Time to recurrence of squamous cell carcinoma of the head and neck. Head Neck 1991;13:277-81.
16. Gleich LL, Ryzenman J, Gluckman JL, Wilson KM, Barrett WL, Redmond KP. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible? Arch Otolaryngol Head Neck Surg 2004;130:35-8.